Literature DB >> 7797596

A possible multiclonal development in human colonic carcinomas.

M Ohmura1, T Hattori.   

Abstract

In order to define whether all colonic tumors develop from a single transformed cell, we compared two sites each in 40 early-stage colonic carcinomas by K-ras mutation and DNA ploidy pattern. These 40 colonic carcinomas consisted of 26 protruding-type carcinomas and 14 superficial-type carcinomas. The two sites were selected in every tumor tissue and then DNA ploidy pattern and occurrence of K-ras mutation were detected. In cases of "cancer in adenoma", we compared clonality between cancer cells and adenoma cells. In a cytofluorometrical study, it was shown that diploid patterns were predominantly seen in protruding-type carcinomas (76.9%), whereas many superficial-type carcinomas (64.3%) consisted of aneuploid cells. K-ras mutations were more frequently observed in protruding-type carcinomas: 42.3% in protruding-type compared to 21.4% in superficial-type carcinomas. These findings suggested that superficial-type carcinomas have a different mode of carcinogenesis from that of protruding-type carcinomas. Frequently, each pair of sites of the carcinoma tissue carried the same K-ras mutation, and DNA ploidy patterns were essentially the same. However, we encountered some cancers that showed different K-ras mutations in the cancer tissues. In particular, one case of cancer in adenoma demonstrated different K-ras mutations in the cancer and adenoma tissue. These findings suggest that most colonic cancers develop monoclonally, but there are a few cancers (fewer than 5%) that start multiclonally.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7797596     DOI: 10.1007/bf01225683

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  12 in total

1.  Do adenomatous polyps become cancer?

Authors:  L V ACKERMAN; J S SPRATT
Journal:  Gastroenterology       Date:  1963-06       Impact factor: 22.682

2.  Do adenomatous polyps of the colon become malignant?

Authors:  B CASTLEMAN; H I KRICKSTEIN
Journal:  N Engl J Med       Date:  1962-09-06       Impact factor: 91.245

3.  Minute cancers arising de novo in the human large intestine.

Authors:  S Kuramoto; T Oohara
Journal:  Cancer       Date:  1988-02-15       Impact factor: 6.860

4.  The anatomical precursor of colorectal carcinoma.

Authors:  C M Fenoglio; N Lane
Journal:  Cancer       Date:  1974-09       Impact factor: 6.860

5.  Multiclonal origin of polyps in Gardner syndrome.

Authors:  S H Hsu; G D Luk; A J Krush; S R Hamilton; H H Hoover
Journal:  Science       Date:  1983-09-02       Impact factor: 47.728

6.  Value of genetic variants of glucose-6-phosphate dehydrogenase in tracing the origin of malignant tumors.

Authors:  E Beutler; Z Collins; L E Irwin
Journal:  N Engl J Med       Date:  1967-02-16       Impact factor: 91.245

7.  Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene.

Authors:  Y Miyoshi; H Nagase; H Ando; A Horii; S Ichii; S Nakatsuru; T Aoki; Y Miki; T Mori; Y Nakamura
Journal:  Hum Mol Genet       Date:  1992-07       Impact factor: 6.150

8.  Clonal analysis of human colorectal tumors.

Authors:  E R Fearon; S R Hamilton; B Vogelstein
Journal:  Science       Date:  1987-10-09       Impact factor: 47.728

9.  The possibility of nonpolypoid carcinogenesis in the large intestine as inferred from frequencies of DNA aneuploidy of polypoid and crater-shaped carcinomas.

Authors:  S Hamada; K Namura; S Fujita
Journal:  Cancer       Date:  1988-10-15       Impact factor: 6.860

10.  Early colorectal carcinoma with special reference to its development de novo.

Authors:  T Shimoda; M Ikegami; J Fujisaki; T Matsui; S Aizawa; E Ishikawa
Journal:  Cancer       Date:  1989-09-01       Impact factor: 6.860

View more
  1 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.